Loading...
Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines for glomerulonephritis shed light on the complex world of glomerulonephritis therapy. However, they may no longer apply to idiopathic membranous nephropathy, as recently concluded by the KDIGO 2019 Working Group....
Na minha lista:
| Udgivet i: | Clin Kidney J |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6768298/ https://ncbi.nlm.nih.gov/pubmed/31583088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfz127 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|